OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study

11 5 2023 07:43:20 提供 Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update

09 5 2023 15:01:03 提供 Nasdaq GlobeNewswire

Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress

08 5 2023 06:06:10 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 5 2023 15:30:57 提供 Nasdaq GlobeNewswire

Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference

13 4 2023 15:30:48 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 4 2023 15:30:50 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic Update

09 3 2023 15:00:17 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 3 2023 16:00:11 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare Conference

02 3 2023 15:05:19 提供 Nasdaq GlobeNewswire

Olema Oncology to Participate at Upcoming Investor Conferences

21 2 2023 15:30:35 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 2 2023 17:00:40 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 1 2023 15:30:01 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 06:00:58 提供 Nasdaq GlobeNewswire

Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation Study

07 12 2022 14:37:49 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 12 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS)

21 11 2022 08:16:07 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update

08 11 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 11 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at Upcoming Investor Conferences in November

01 11 2022 07:00:02 提供 Nasdaq GlobeNewswire

Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical Trial

26 10 2022 02:00:00 提供 Nasdaq GlobeNewswire